Office of Research Commercialization, Texas Tech University

Submit a New Inquiry

Technology #d-1154 - Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening

Office of Research Commercialization, Texas Tech University contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.

Optional

Optional

By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant